Is Affimed N.V. (AFMD) a Buy, Sell, or Hold?
NASDAQ : AFMD
Affimed N.V. — Institutional Ownership
$0.1815 USD
$0 (0.0%)
- Volume
- 22.06M
- Average Volume
- 15.65M
- Market Capitalization
- $2.98M
- P/E Ratio
- -0.02
- Dividend Yield
- 0.00%
- Price Target
- $7.50
- Year High
- $8.95
- Year Low
- $0.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.25
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2025-05-20 | Ridgeback Capital Investments L.P. | - | 0.00% |
| 2025-02-14 | 683 Capital Management, LLC | 654.6K | 4.30% |
| 2024-10-24 | 683 Capital Partners, LP | 924.6K | 6.10% |
| 2024-10-24 | Ari Zweiman | 924.6K | 6.10% |
| 2024-10-24 | 683 Capital Management, LLC | 924.6K | 6.10% |
| 2022-04-21 | Manapouri B.V. (100% owned by Edwin de Graaf) | 8.12M | 5.60% |
| 2022-04-21 | Martemanshurk B.V. (100% owned by Pieter van der Meer) | 8.12M | 5.60% |
| 2022-04-21 | Cooperatieve Gilde Healthcare V U.A. | 8.12M | 5.60% |
| 2022-04-21 | Gilde Healthcare Holding B.V. | 8.12M | 5.60% |
| 2022-04-21 | Gilde Healthcare V Management B.V. | 8.12M | 5.60% |
| 2022-02-14 | Cubist Systematic Strategies, LLC | 439.0 | 4.00% |
| 2022-02-14 | Point72 Asset Management, L.P. | 11.86M | 4.00% |
| 2022-02-14 | 42-1684320 | 7.72M | 6.50% |
| 2022-02-14 | Point72 Capital Advisors, Inc. | 11.86M | 4.00% |
| 2022-02-14 | Point72 Hong Kong Limited | - | 4.00% |
| 2022-02-14 | Steven A. Cohen | 11.86M | 4.00% |
| 2022-02-14 | 66-0677421 | 7.72M | 6.50% |
| 2022-02-14 | 72-1614961 | 7.72M | 6.50% |
| 2022-02-07 | 683 Capital Partners, LP | 6.25M | 5.20% |
| 2022-02-07 | 683 Capital Management, LLC | 6.25M | 5.20% |
| 2022-02-07 | Ari Zweiman | 6.25M | 5.20% |
| 2021-04-14 | 66-0677421 | 6.45M | 5.50% |
| 2021-04-14 | 42-1684320 | 6.45M | 5.50% |
| 2021-04-14 | 72-1614961 | 6.45M | 5.50% |
| 2021-02-08 | Steven A. Cohen | 5.81M | 4.00% |
| 2021-02-08 | Point72 Asset Management, L.P. | 5.64M | 4.00% |
| 2021-02-08 | Point72 Capital Advisors, Inc. | 5.64M | 4.00% |
| 2021-02-08 | Cubist Systematic Strategies, LLC | 177.49K | 4.00% |
| 2021-02-08 | Point72 Hong Kong Limited | 1619.0 | 4.00% |
| 2020-12-18 | Morgan Stanley | 4.77M | 5.40% |
| 2020-06-17 | Assenagon S.A., Assenagon Asset Management S.A. | 779.0 | 1.02% |
| 2020-06-16 | Assenagon S.A., Assenagon Asset Management S.A. | 779.0 | 1.02% |
| 2020-06-16 | Assenagon S.A., Assenagon Asset Management S.A. | 4.98M | 6.53% |
| 2020-05-26 | Millennium International Management LP | 240.62K | 0.30% |
| 2020-05-26 | Integrated Assets II LLC | 240.62K | 0.30% |
| 2020-05-26 | Israel A. Englander | 4.63M | 6.10% |
| 2020-05-26 | Millennium Management LLC | 4.63M | 6.10% |
| 2020-05-26 | Integrated Core Strategies (US) LLC | 4.38M | 5.80% |
| 2020-05-26 | Millennium Group Management LLC | 4.63M | 6.10% |
| 2020-02-13 | Stonepine Capital, L.P. | 4.01M | 11.00% |
| 2020-02-13 | Stonepine Capital Management, LLC | 4.01M | 11.00% |
| 2020-02-13 | Timothy P. Lynch | 4.01M | 11.00% |
| 2020-02-13 | Jon M. Plexico | 4.01M | 11.00% |
| 2019-12-16 | Jon M. Plexico | 4.59M | 11.00% |
| 2019-12-16 | Stonepine Capital, L.P. | 4.59M | 11.00% |
| 2019-12-16 | Stonepine Capital Management, LLC | 4.59M | 11.00% |
| 2019-12-16 | Timothy P. Lynch | 4.59M | 11.00% |
| 2019-02-14 | Brookside Capital Investors II, L.P. | 2.36M | 2.00% |
| 2019-02-14 | Brookside Capital Trading Fund, L.P. | 2.36M | 3.00% |
| 2019-02-14 | Bain Capital Public Equity Management, LLC | 2.36M | 1.00% |
| 2019-01-25 | Novo Nordisk A/S | 123.32K | 0.20% |
| 2018-02-08 | Novo Nordisk A/S | 2.66M | 6.10% |
| 2017-03-10 | Hawkes Bay Master Investors (Cayman) L.P. | 2.18M | 5.04% |
| 2017-02-03 | Jon M. Sakoda | 3.89M | 9.00% |
| 2017-02-03 | Forest Baskett | 3.89M | 9.00% |
| 2017-02-03 | NEA Partners 15, L.P. | 3.89M | 9.00% |
| 2017-02-03 | New Enterprise Associates 15, L.P. | 3.89M | 9.00% |
| 2017-02-03 | Growth Equity Opportunities Fund IV, LLC | 3.89M | 9.00% |
| 2017-02-03 | Joshua Makower | 3.89M | 9.00% |
| 2017-02-03 | Anthony A. Florence, Jr. | 3.89M | 9.00% |
| 2017-02-03 | David M. Mott | 3.89M | 9.00% |
| 2017-02-03 | Scott D. Sandell | 3.89M | 9.00% |
| 2017-02-03 | Peter W. Sonsini | 3.89M | 9.00% |
| 2017-02-03 | Peter J. Barris | 3.89M | 9.00% |
| 2017-02-03 | NEA 15 GP, LLC | 3.89M | 9.00% |
| 2017-02-03 | Ravi Viswanathan | 3.89M | 9.00% |
| 2017-01-27 | OrbiMed Advisors LLC | 3.06M | 7.06% |
| 2017-01-27 | Samuel D. Isaly | 3.06M | 7.06% |
| 2017-01-27 | OrbiMed Capital GP III LLC | 3.03M | 7.00% |
| 2016-06-16 | Novo Nordisk A/S | 2.86M | 8.60% |
| 2016-04-11 | Wellington Investment Advisors Holdings LLP | 3.56M | 10.71% |
| 2016-04-11 | Wellington Management Group LLP | 3.56M | 10.71% |
| 2016-04-11 | Wellington Management Company LLP | 3.43M | 10.31% |
| 2016-04-11 | Wellington Group Holdings LLP | 3.56M | 10.71% |
| 2015-02-17 | Novo Nordisk A/S | 2.73M | 23.00% |
| 2015-02-17 | (German Cancer Research Center) | 28001.0 | 23.00% |
| 2015-02-17 | LSP III Omni Investment Coöperatief U.A. | 1.56M | 23.00% |
| 2015-02-17 | BioMedInvest I Limited | 1.56M | 23.00% |
| 2015-02-17 | Prof. Dr. Melvyn Little | 151.08K | 23.00% |
| 2015-02-17 | LSP III Management B.V. | 1.56M | 23.00% |
| 2014-09-24 | KfW | 335.28K | 1.40% |
| 2014-09-23 | Deutsches Krebsforschungszentrum (German Cancer Research Center) | 28001.0 | 0.12% |
| 2014-09-23 | tbg Technologie-Beteiligungs-Gesellschaft mbH Technology Participation Company | 300.4K | 1.30% |
| 2014-09-22 | LSP III Omni Investment Coöperatief U.A. | 1.56M | 6.50% |
| 2014-09-22 | LSP III Management B.V. | 1.56M | 6.50% |
| 2014-09-22 | Novo Nordisk A/S | 2.73M | 11.40% |
| 2014-09-22 | BioMedInvest I Limited | 1.0 | 6.50% |
| 2014-09-22 | Sagittarius Holding AG (“SGR”) | 5.33M | 22.20% |
| 2014-09-22 | Holding GmbH | 5.89M | 24.60% |
| 2014-09-22 | h.c. Klaus Tschira | 5.89M | 24.60% |
| 2014-09-19 | Samuel D. Isaly | 5.81M | 24.24% |
| 2014-09-19 | OrbiMed Advisors LLC | 5.81M | 24.24% |
| 2014-09-19 | OrbiMed Capital GP III LLC | 5.76M | 24.02% |
AFMD Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2023-12-31 | $5.65 | 14.94M | $84.48M | $38.53M | $19.35M | $65.3M |
| 2022-12-31 | $11.58 | 14.24M | $164.86M | $190.29M | $18.19M | -$7.24M |
| 2021-12-31 | $48.54 | 11.95M | $580.1M | $197.63M | $18.69M | $401.16M |
| 2020-12-31 | $47.62 | 8.35M | $397.49M | $146.85M | $1.3M | $251.93M |
| 2019-12-31 | $24.43 | 6.42M | $156.96M | $95.23M | $3.19M | $64.91M |
| 2018-12-31 | $27.12 | 6.05M | $164.11M | $94.83M | $4.77M | $74.05M |
| 2017-12-31 | $11.45 | 4.37M | $50.11M | $39.84M | $7.17M | $17.44M |
| 2016-12-31 | $17.09 | 3.32M | $56.77M | $35.41M | $4.59M | $25.95M |
| 2015-12-31 | $65.56 | 2.85M | $186.7M | $76.74M | $4.58M | $114.54M |
| 2014-12-31 | $51.23 | 2.59M | $132.69M | $39.72M | $3.9M | $96.86M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2024-09-30 | $3.02 | 16.1M | $48.57M | $7.4M | $12.89M | $54.06M |
| 2024-06-30 | $5.04 | 15.3M | $77.13M | $10.76M | $14.52M | $80.88M |
| 2024-03-31 | $5.91 | 15.13M | $89.4M | $14.35M | $16.07M | $91.12M |
| 2023-12-31 | $5.65 | 14.94M | $84.48M | $38.53M | $19.35M | $65.3M |
| 2023-09-30 | $4.52 | 14.93M | $67.49M | $62.82M | $21.08M | $25.75M |
| 2023-06-30 | $5.48 | 14.93M | $81.85M | $120.06M | $15.25M | -$22.96M |
| 2023-03-31 | $6.88 | 14.93M | $102.72M | $155.85M | $16.72M | -$36.41M |
| 2022-12-31 | $11.58 | 14.93M | $172.94M | $190.29M | $18.19M | $843.32K |
| 2022-09-30 | $21.02 | 14.93M | $313.95M | $222.9M | $18.73M | $109.78M |
| 2022-06-30 | $26.43 | 14.73M | $389.36M | $237.23M | $18.8M | $170.93M |
| 2022-03-31 | $39.47 | 12.34M | $487.29M | $169.85M | $18.63M | $336.07M |
| 2021-12-31 | $48.54 | 12.24M | $594.03M | $197.63M | $18.69M | $415.1M |